Why Patchwork Senate Drug Bills are No Substitute for MedicareReform

Members of Congress should undertake structural improvements inMedicare that will ensure seniors have access to medical innovationand technology within a market-based framework that ensurescompetition, choice, and quality.

Related Keywords

United States ,Canada ,Americans ,America ,American ,Canadians ,Canadian ,William Hubbard ,Donna Shalala ,Merrill Matthews ,Tommy Thompson ,Health Benefits Program ,Bush Administration ,National Bipartisan Commission ,Human Services ,Members Of Congress ,Drug Administration ,Pensions Committee ,Senate Medicare ,Senate Special Committee On ,Greater Access To Affordable Pharmaceuticals ,Why Senate Drug Policies ,Clinton Administration ,Senate Health ,Institute For Policy Innovation ,Federal Employees Health Benefits Program ,Prescription Drug Price Parity ,Americans Act ,Senator Byron Dorgan ,Senate Special Committee ,Senior Associate Commissioner William Hubbard ,Secretary Tommy Thompson ,Greater Access ,Affordable Pharmaceuticals Act ,Senator Chuck Schumer ,Senator John Mccain ,Hatch Waxman Act ,Visiting Scholar ,Policy Innovation ,Price Competition ,Patent Term Restoration ,Orrin Hatch ,Senator Hatch ,Health Care ,Medicare ,Reform ,Ina Owcharenk ,Drug Bill ,